Q3 2024 Earnings Call Transcript November 14, 2024 Operator: Welcome to the Biofrontera Inc. Third Quarter 2024 Financial ...

With gold re-establishing itself as the leading monetary reserve asset for central banks worldwide, the quantities of ...

Company reported $0 in product shipments in the third quarter of 2024 and recognized negative net product revenue of $1.9 million, including a ...

Conclusion: Integrated Goods and Services Tax ( IGST ) on ocean freight could not be levied on Free on Board ( FOB ) ...

The ASX wobbled again on Tuesday, with the S&P/ASX 200 down 0.34 per cent at 1pm, adding to Monday’s 0.4 per cent drop.

The operating income decline compared with the prior year reflects, among other things, increased labor and energy costs and a loss incurred on a large capital equipment sale. Life Sciences ... terms ...

Q3 2024 Earnings Call Transcript November 4, 2024 Krystal Biotech, Inc. beats earnings expectations. Reported EPS is $0.909, expectations were $0.9. Operator: Thank you for standing by and welcome to ...

Q3 2024 Earnings Conference Call November 4, 2024 8:30 AM ET. Company Participants. Stéphane Paquette - VP, Corporate Development Krish Krishn ...

Centrus energy Corp. (NYSE American: LEU) ("Centrus") today announced its intention to offer, subject to market conditions and other factors, $350 million aggregate principal amount of Convertible ...

The AI-based algorithms showed improved performance with more clinical data, allowing EMVision to proceed with a validation ...

Obtain regulatory clearance for clinical use ... we have cleared the first stage gate in our clinical product development process and submitted a Q-Sub to the FDA. Specifically, Oncocyte has submitted ...